Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 434-441

  Smit, Justin K ^a   Faber, Hette ^a   Niemantsverdriet, Maarten ^a   Baanstra, Mirjam ^a   Bussink, Johan ^b   Hollema, Harry ^a   Van Os, Ronald P ^a   Plukker, John Th M ^a   Coppes, Robert P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer stem cells; Chemoradiotherapy; Esophageal cancer; Radiotherapy; Response

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL ACTIVITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; TREATMENT RESPONSE; TUMOR BIOPSY;

CANCER STEM CELLS; CHEMORADIOTHERAPY; ESOPHAGEAL CANCER; RADIOTHERAPY; RESPONSE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; MICE; MICE, SCID; NEOPLASTIC STEM CELLS;

EID: 84881474210     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.03.027     Document Type: Article

References (46)

1. C. Mariette, G. Piessen, and J.P. Triboulet Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities Lancet Oncol 8 2007 545 553
2. L.M. Brown, S.S. Devesa, and W.H. Chow Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age J Natl Cancer Inst 100 2008 1184 1187
3. L.M. Crane, M. Schaapveld, O. Visser, M.W. Louwman, J.T. Plukker, and G.M. van Dam Oesophageal cancer in the Netherlands: increasing incidence and mortality but improving survival Eur J Cancer 43 2007 1445 1451
4. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
5. J.M. Omloo, S.M. Lagarde, and J.B. Hulscher Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial Ann Surg 246 2007 992 1000 [discussion 1000-1]
6. J.K. Smit, B.B. Pultrum, H.M. van Dullemen, G.M. Van Dam, H. Groen, and J.T. Plukker Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy Am J Surg 200 2010 446 453
7. V. Gebski, B. Burmeister, and B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
8. P. van Hagen, M.C. Hulshof, and J.J. van Lanschot Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
9. N.P. Nguyen, S.P. Krafft, and V. Vinh-Hung Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy Radiother Oncol 101 2011 438 442
10. P. Lambin, R.G. van Stiphout, and M.H. Starmans Predicting outcomes in radiation oncology-multifactorial decision support systems Nat Rev Clin Oncol 10 2012 27 40
11. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
12. L. Zhu, P. Gibson, and D.S. Currle Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation Nature 457 2009 603 607
13. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
14. L. Vermeulen, E. De Sousa, F. Melo, and M. van der Heijden Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat Cell Biol 12 2010 468 476
15. K. Oonishi, X. Cui, and H. Hirakawa Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells Radiother Oncol 105 2012 258 265
16. T.M. Phillips, W.H. McBride, and F. Pajonk The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation J Natl Cancer Inst 98 2006 1777 1785
17. M. Todaro, M.P. Alea, and A.B. Di Stefano Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 2007 389 402
18. S. Takaishi, T. Okumura, and S. Tu Identification of gastric cancer stem cells using the cell surface marker CD44 Stem Cells 27 2009 1006 1020
19. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554
20. A.C. Begg Predicting recurrence after radiotherapy in head and neck cancer Semin Radiat Oncol 22 2012 108 118
21. M.C. de Jong, J. Pramana, and J.L. Knegjens HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors Radiother Oncol 95 2010 365 370
22. K. Gurtner, F. Hessel, and W. Eicheler Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo Radiother Oncol 102 2012 444 449
23. K. Gurtner, Y. Deuse, and R. Butof Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression Radiother Oncol 99 2011 323 330
24. D. Huang, Q. Gao, and L. Guo Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines Stem Cells Dev 18 2009 465 473
25. B.A. Grotenhuis, W.N. Dinjens, and B.P. Wijnhoven Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers J Pathol 221 2010 379 389
26. L. Ricci-Vitiani, D.G. Lombardi, and E. Pilozzi Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
27. Z.F. Yang, D.W. Ho, and M.N. Ng Significance of CD90+ cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
28. P. Dalerba, S.J. Dylla, and I.K. Park Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2007 10158 10163
29. G. Dontu, K.W. Jackson, E. McNicholas, M.J. Kawamura, W.M. Abdallah, and M.S. Wicha Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells Breast Cancer Res 6 2004 R605 R615
30. S. Liu, G. Dontu, and I.D. Mantle Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells Cancer Res 66 2006 6063 6071
31. J.C. Rockett, K. Larkin, S.J. Darnton, A.G. Morris, and H.R. Matthews Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization Br J Cancer 75 1997 258 263
32. I.M. Lombaert, J.F. Brunsting, and P.K. Wierenga Rescue of salivary gland function after stem cell transplantation in irradiated glands PLoS One 3 2008 e2063
33. A.I. Khramtsov, G.F. Khramtsova, M. Tretiakova, D. Huo, O.I. Olopade, and K.H. Goss Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome Am J Pathol 176 2010 2911 2920
34. S.E. Rademakers, J. Lok, A.J. van der Kogel, J. Bussink, and J.H. Kaanders Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4 BMC Cancer 11 2011 167
35. T.M. Yeung, S.C. Gandhi, J.L. Wilding, R. Muschel, and W.F. Bodmer Cancer stem cells from colorectal cancer-derived cell lines Proc Natl Acad Sci U S A 107 2010 3722 3727
36. S. Deng, X. Yang, and H. Lassus Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS One 5 2010 e10277
37. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
38. D.L. Schwartz, J. Bankson, and L. Bidaut HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance Mol Cancer Res 9 2011 259 270
39. M.C. McGee, J.B. Hamner, and R.F. Williams Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation Int J Radiat Oncol Biol Phys 76 2010 1537 1545
40. S.J. Conley, E. Gheordunescu, and P. Kakarala Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia Proc Natl Acad Sci U S A 109 2012 2784 2789
41. R.V. Scheer, A.J. Fakiris, and P.A. Johnstone Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer Int J Radiat Oncol Biol Phys 80 2011 996 1001
42. A.C. Berger, J. Farma, and W.J. Scott Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 2005 4330 4337
43. D.P. Doupe, M.P. Alcolea, and A. Roshan A single progenitor population switches behavior to maintain and repair esophageal epithelium Science 337 2012 1091 1093
44. T. Winder, Y. Ning, and D. Yang Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma Int J Cancer 129 2011 1096 1104
45. M.C. de Jong, J. Pramana, and J.E. van der Wal CD44 expression predicts local recurrence after radiotherapy in larynx cancer Clin Cancer Res 16 2010 5329 5338
46. J.S. Zhao, W.J. Li, and D. Ge Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44 PLoS One 6 2011 e21419